What is Primmune Therapeutics worth?
$44.0Mlast known valuation
Primmune Therapeutics last raised $13.0M in its Early Stage VC (Oct 2020).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Primmune Therapeutics
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2020 | Early Stage VC | $13.0M | ▮ | ▮ |
| Feb 2020 | Seed Round | $2.5M | ▮ | ▮ |
| Feb 2019 | Seed Round | $2.0M | ▮ | ▮ |
| Jul 2018 | Seed Round | $1.1M | ▮ | ▮ |
| Oct 2017 | Seed Round | $1.5M | ▮ | ▮ |
How Primmune Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Primmune Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Primmune Therapeutics worth?
- Primmune Therapeutics's last known valuation is $44.0M.
- How much has Primmune Therapeutics raised?
- Primmune Therapeutics has raised $63.2M in total funding across 5 recorded rounds.
- When did Primmune Therapeutics last raise?
- Primmune Therapeutics last raised in Oct 2020 (Early Stage VC), raising $13.0M.